article_metadata: Kathryn E Beckermann Pradeep C Jolly Ju Y Kim Jennifer Bordeaux Igor Puzanov W Kimryn Rathmell Douglas B Johnson
article_metadata: 10.1186/s40425-016-0206-1
article_metadata: J Immunother Cancer
article_metadata: 2017 Jan 17;5:1.
article_metadata: nivolumab pd-1 renal cell carcinoma renal medullary carcinoma
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/28105368/
article_metadata: Carcinoma, Medullary / therapy Kidney Neoplasms / therapy Programmed Cell Death 1 Receptor / immunology Tumor Microenvironment / drug effects
article_metadata: Carcinoma, Medullary / therapy Kidney Neoplasms / therapy Programmed Cell Death 1 Receptor / immunology Tumor Microenvironment / drug effects Case Reports Adult Antibodies, Monoclonal / administration & dosage Carcinoma, Medullary / genetics Carcinoma, Medullary / immunology Carcinoma, Medullary / pathology Female Humans Kidney Neoplasms / genetics Kidney Neoplasms / immunology Male Neoplasm Metastasis Nivolumab Programmed Cell Death 1 Receptor / antagonists & inhibitors Programmed Cell Death 1 Receptor / genetics Tumor Microenvironment / immunology Antibodies, Monoclonal PDCD1 protein, human Programmed Cell Death 1 Receptor Nivolumab
article_metadata: PMC5240268
article_metadata: 28105368
article_metadata: Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
article_metadata: 2017